Author: Eve Kennedy

08 Aug 2023 CARLA GALLASCH ACCEPTED INTO NATIONAL INDUSTRY PHD PROGRAM

Posted at 09:00h in Announcements

Adelaide, Australia, 8th August 2023 GPN Vaccines is pleased to announce our recent success in the Australian Government’s National Industry PhD Program. The funding secured by the University of Adelaide’s Dr Erin Brazel, PhD student Carla Gallasch, and GPN Vaccines will support Carla to take part...

07 Aug 2023 GPN VACCINES REACHES 100% RECRUITMENT MILESTONE IN PHASE I CLINICAL TRIAL

Posted at 17:19h in Announcements

Adelaide, Australia, 7th August 2023 GPN Vaccines is pleased to announce that the Phase I clinical trial of Gamma-PN is now fully recruited. The Phase I clinical trial is assessing the safety, tolerability and immunogenicity of Gamma-PN – a novel broad-spectrum pneumococcal vaccine. One hundred and...

Protecting children and adults from the world’s foremost bacterial pathogen

Author: Eve Kennedy

08 Aug 2023 CARLA GALLASCH ACCEPTED INTO NATIONAL INDUSTRY PHD PROGRAM

07 Aug 2023 GPN VACCINES REACHES 100% RECRUITMENT MILESTONE IN PHASE I CLINICAL TRIAL

Meet us at

Follow us on social media

Subscribe Here